Background: Diabetes mellitus (DM) is a known risk factor for xerostomia. Oral health-related quality of life (OHRQoL) is a multi-dimensional issue reflecting several effects of the oral condition on the quality of life.
Objectives: The present study aimed to assess OHRQoL and its relationship with xerostomia severity in type 2 diabetic patients.
Material And Methods: A total of 200 patients participated in this cross-sectional study. The Xerostomia Inventory (XI) assessed xerostomia severity and the Oral Health Impact Profile-14 (OHIP-14) questionnaire evaluated OHRQoL. In addition, the fasting blood sugar (FBS) and glycated hemoglobin (HbA1c) tests were conducted, and the results were recorded, as well as the disease duration and denture wearing. Data analysis employed the t test and Pearson's correlation coefficient.
Results: The mean XI score was 22.27 ±6.92 and the mean OHIP-14 score was 13.76 ±8.41. The mean FBS, HbA1c and disease duration values were 161.23 ±49.14 mg/dL, 7.90 ±1.12% and 11.02 ±7.78 years, respectively. The OHIP-14 score correlated significantly with the XI score, age, FBS, HbA1c, the disease duration, and denture wearing (p < 0.05).
Conclusions: There was a significant correlation between OHRQoL and xerostomia severity in patients with type 2 DM. Age, denture wearing, the disease duration, and the medical management of DM also correlated significantly with OHRQoL. Treating both the underlying disease and oral health comorbidities, such as xerostomia, seems to be essential for achieving a better OHRQoL in type 2 diabetic patients.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.17219/dmp/147754 | DOI Listing |
Arthritis Res Ther
January 2025
Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, the Ministry of Education Key Laboratory, Chinese Academy of Medical Sciences & Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases, Beijing, China.
Objective: Severe gastrointestinal lesions are associated with a poor prognosis in eosinophilic granulomatosis with polyangiitis (EGPA). The goal of this study was to develop an effective predictive model for gastrointestinal lesions and to examine clinical patterns, associated factors, treatment, and outcomes of gastrointestinal lesions in EGPA.
Methods: We retrospectively enrolled 165 EGPA patients.
J Med Case Rep
January 2025
Headache Department, Iranian Center of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
Background: Idiopathic intracranial hypertension (IIH) is a condition where the pressure of the cerebrospinal fluid in the brain increases without a known cause. It typically affects adults but can also occur in adolescents and children, although it is less common. Numerous elements, including coagulopathy, have been documented in previous cases as potential etiological factors of IIH.
View Article and Find Full Text PDFJ Immunother Cancer
January 2025
Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Background: Immune checkpoint inhibitors (ICIs) are recommended to treat patients with deficient mismatch repair/microsatellite instability high (dMMR/MSI-H) metastatic colorectal cancer (mCRC). Pivotal trials have fixed a maximum ICI duration of 2 years, without a compelling rationale. A shorter treatment duration has the potential to improve patients' quality of life and reduce both toxicity and cost without compromising efficacy.
View Article and Find Full Text PDFObjective: This study aimed to assess the effect of home-based exercise interventions on walking performance in patients with peripheral artery disease (PAD) and intermittent claudication (IC).
Design: Systematic review and meta-analysis.
Data Sources: We searched the Medline, Web of Science, Embase, Scopus and Cochrane Library databases to identify randomised controlled trials of patients with PAD and IC published in English up to August 2024.
BMJ Open
January 2025
Center for Human Nutrition, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA
Introduction: Optimising the micronutrient status of women before and during reproduction confers benefits to them and their offspring. Antenatal multiple micronutrient supplements (MMS), given as a daily tablet with nutrients at ~1 recommended dietary allowance (RDA) or adequate intake (AI) reduces adverse birth outcomes. However, at this dosage, MMS may not fully address micronutrient deficiencies in settings with chronically inadequate diets and infection.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!